Stock GENI GENINCODE PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News GENinCode Plc

Equities

GENI

GB00BL97B504

Market Closed - London S.E.
Other stock markets
 11:35:26 2024-05-17 EDT 		5-day change 1st Jan Change
8.75 GBX 0.00% Intraday chart for GENinCode Plc -9.09% +66.67%
04-04 GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort CI
03-21 GENinCode says ROCA recommended as ovarian cancer risk test in England AN

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort
CI
GENinCode says ROCA recommended as ovarian cancer risk test in England
AN
GENinCode gets GBP57,000 in retail offer, well below maximum
AN
GENinCode Raises GBP4 Million from Share Sale
MT
GENinCode raises GBP4 million via placing and subscription
AN
Genincode Plc Announces Placing And Subscription To Raise A Minimum Of £4.0 Mln
RE
Aura eyes Tiris expansion; Kavango backs Pambili
AN
GENinCode plc Agrees with the Food and Drug Administration to Create New Regulatory Class for Polygenic Risk scores and Transition Its Premarket Notification 510(K) Submission to A De Novo Pathway
CI
EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up
AN
Earnings Flash (GENI.L) GENINCODE Reports H1 Revenue GBP950,000
MT
Earnings Flash (GENI.L) GENINCODE Posts H1 Loss GBX-3.33
MT
GENinCode Plc Provides Revenue Guidance for the Second Half of 2023
CI
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Genincode plc Announces CARDIO inCode study on risk of incident Coronary Heart Disease
CI
GENinCode Shares Rise on FDA Filing for Heart Disease Test Kit
DJ
GENinCode Submits Premarket Notification for US Commercial Distribution of Polygenic Test Kit
MT
GENinCode plc Files its Premarket Notification with the Food and Drug Administration to Expand Its US Commercial Distribution of the Cardio InCode-Score Polygenic Test for the Risk Assessment and Prevention of Coronary Heart Disease
CI
Certain Ordinary Shares of GENinCode Plc are subject to a Lock-Up Agreement Ending on 23-JUL-2023.
CI
GENinCode Shares Rise Amid US Partnership with MedStar Health
MT
GENinCode and MedStar collaborate on coronary heart disease testing
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GENI Stock
  4. News GENinCode Plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW